Oramed Pharmaceuticals Inc. (ORMP.TA)
ILA 843.3
(0.33%)
ILA 843.3
(0.33%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2022 | -3.30 USD | -32.0% |
| 2021 | -2.50 USD | -32.98% |
| 2020 | -1.88 USD | 35.17% |
| 2019 | -2.90 USD | 5.84% |
| 2018 | -3.08 USD | -9.22% |
| 2017 | -2.82 USD | 14.29% |
| 2016 | -3.29 USD | -25.1% |
| 2015 | -2.63 USD | -19.55% |
| 2014 | -2.20 USD | -3.29% |
| 2013 | -2.13 USD | 6.58% |
| 2012 | -2.28 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q3 | -0.30 USD | -172.73% |
| 2023 Q1 | -0.31 USD | 59.21% |
| 2023 Q2 | -0.11 USD | 64.52% |
| 2022 Q3 | -0.64 USD | 32.63% |
| 2022 FY | - USD | -32.0% |
| 2022 Q1 | -0.86 USD | 16.5% |
| 2022 Q2 | -0.95 USD | -10.47% |
| 2022 Q4 | -0.76 USD | -18.75% |
| 2021 Q3 | -0.67 USD | -17.54% |
| 2021 Q4 | -1.03 USD | -53.73% |
| 2021 Q1 | -0.57 USD | 26.92% |
| 2021 Q2 | -0.57 ILA | 0.0% |
| 2021 FY | - USD | -32.98% |
| 2020 Q3 | -0.43 USD | -22.86% |
| 2020 Q2 | -0.35 USD | 51.39% |
| 2020 Q4 | -0.78 USD | -81.4% |
| 2020 Q1 | -0.72 USD | -41.18% |
| 2020 FY | - USD | 35.17% |
| 2019 Q1 | -0.77 USD | 16.3% |
| 2019 Q2 | -0.85 USD | -10.39% |
| 2019 FY | - USD | 5.84% |
| 2019 Q4 | -0.51 USD | -10.87% |
| 2019 Q3 | -0.46 USD | 45.88% |
| 2018 Q4 | -0.92 USD | -41.54% |
| 2018 Q1 | -0.70 USD | -12.9% |
| 2018 Q3 | -0.65 USD | 39.25% |
| 2018 Q2 | -1.07 USD | -52.86% |
| 2018 FY | - USD | -9.22% |
| 2017 Q2 | -0.52 USD | 40.23% |
| 2017 Q4 | -0.62 USD | 13.89% |
| 2017 FY | - USD | 14.29% |
| 2017 Q1 | -0.87 USD | -14.47% |
| 2017 Q3 | -0.72 USD | -38.46% |
| 2016 Q3 | -1.37 USD | -132.2% |
| 2016 FY | - USD | -25.1% |
| 2016 Q4 | -0.76 USD | 44.53% |
| 2016 Q2 | -0.59 USD | -5.36% |
| 2016 Q1 | -0.56 USD | 30.0% |
| 2015 Q2 | -0.57 USD | 5.0% |
| 2015 Q1 | -0.60 USD | 17.81% |
| 2015 FY | - USD | -19.55% |
| 2015 Q4 | -0.80 USD | -11.11% |
| 2015 Q3 | -0.72 USD | -26.32% |
| 2014 Q2 | -0.64 USD | -48.84% |
| 2014 Q1 | -0.43 USD | 14.0% |
| 2014 Q3 | -0.58 USD | 9.38% |
| 2014 Q4 | -0.73 USD | -25.86% |
| 2014 FY | - USD | -3.29% |
| 2013 FY | - USD | 6.58% |
| 2013 Q1 | -0.63 USD | -16.67% |
| 2013 Q3 | -0.38 USD | 40.63% |
| 2013 Q4 | -0.50 USD | -31.58% |
| 2013 Q2 | -0.64 USD | -1.59% |
| 2012 Q3 | -0.89 USD | 0.0% |
| 2012 Q4 | -0.54 USD | 39.33% |
| 2012 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|